PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
Muñoz-Gámez JA, Martín-Oliva D, Aguilar-Quesada R, Cañuelo A, Nuñez MI, Valenzuela MT, Ruiz de Almodóvar JM, De Murcia G, Oliver FJ.
Muñoz-Gámez JA, et al. Among authors: de murcia g, ruiz de almodovar jm.
Biochem J. 2005 Feb 15;386(Pt 1):119-25. doi: 10.1042/BJ20040776.
Biochem J. 2005.
PMID: 15456408
Free PMC article.